Skip to main content

Table 3 Neural network prediction

From: Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection

Sample ID

ANN classification values

Neural network designation

Clinical designation

2

-0.085

Normal

Normal

3

-0.065

Normal

Normal

4

-0.045

Normal

Normal

6

-0.04

Normal

Normal

7

-0.02

Normal

Normal

8

-0.01

Normal

Normal

10

-0.01

Normal

Normal

11

0

Normal

Normal

12

0.02

Normal

Normal

13

0.03

Normal

Normal

14

0.052

Normal

Normal

15

0.059

Normal

Normal

20

0.073

Normal

Normal

21

0.078

Normal

Normal

22

0.092

Normal

Normal

29

0.105

Normal

Normal

31

0.112

Normal

Normal

32

0.118

Normal

Normal

34

0.122

Normal

Normal

35

0.1255

Normal

Normal

18

0.97

PD-Stage 1

PD-Stage 1

23

0.97

PD-Stage 1

PD-Stage 1

24

0.98

PD-Stage 1

PD-Stage 1

26

0.99

PD-Stage 1

PD-Stage 1

1

1.01

PD-Stage 1

PD-Stage 1

27

1.531

PD-Stage 2

PD-Stage 1*

5

1.62

PD-Stage 2

PD-Stage 2

17

1.73

PD-Stage 2

PD-Stage 2

25

1.97

PD-Stage 2

PD-Stage 2

28

1.97

PD-Stage 2

PD-Stage 2

30

1.99

PD-Stage 2

PD-Stage 2

9

2.46

PD-Stage 3

PD-Stage 3

16

2.56

PD-Stage 3

PD-Stage 3

19

2.82

PD-Stage 3

PD-Stage 3

33

2.96

PD-Stage 3

PD-Stage 3

  1. *Sample ID: Misclassified stage 1 as stage 2 by ANN
  2. Neural network classification values, neural network designation and disease designation, for 35 Individuals who have known clinical information. Individuals denoted by a (*) indicates the misclassification of PD stage1 as stage2 by ANN.